Permeation enhancer nanovesicles mediated topical delivery of curcumin for the treatment of hyperpigmentation

The main aim of the present study was to develop curcumin (CUR) loaded permeation enhancer-lipid vesicles for the treatment of hyperpigmentation. Hyperpigmentation is an acquired skin disorder characterized by uneven skin coloration, mainly in the regions of the facial skin, affecting millions of people worldwide. It often occurs in visible areas, hence causing significant negative psychological and social impacts. In the present study, curcumin-loaded permeation enhancer nanovesicles (PE-NVs) were developed by modified ethanol injection method and dimethyl sulfoxide was added as a penetration enhancer. PE-NVs were subjected to various physicochemical characterizations and drug permeation studies across the skin. The PE-NVs were tested for their efficacy in a sunlight-induced hyperpigmented rabbit skin model. Topical application of PE-NVs reduced symptoms of hyperpigmentation as compared with CUR methanolic solution because of higher accumulation because of better permeation into skin layers. Histopathological studies also confirmed the effectiveness of PE-NVs, since they reduced hyperpigmentation-induced lesions. Results confirmed that PE-NVs is a potential drug delivery system for topical administration drugs to treat skin-associated inflammatory disorders.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:32

Enthalten in:

Journal of liposome research - 32(2022), 4 vom: 16. Dez., Seite 332-339

Sprache:

Englisch

Beteiligte Personen:

Farooqui, Raziya Khatoon [VerfasserIn]
Kaurav, Monika [VerfasserIn]
Kumar, Manoj [VerfasserIn]
Sudheesh, M S [VerfasserIn]
Pandey, Ravi Shankar [VerfasserIn]

Links:

Volltext

Themen:

Curcumin
Hyperpigmentation
IT942ZTH98
Journal Article
Lipid nanovesicles
Liposomes
Penetration enhancer
Topical delivery

Anmerkungen:

Date Completed 06.12.2022

Date Revised 06.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/08982104.2021.2024567

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM336330952